Compounds > uredofos
Page last updated: 2024-11-10

uredofos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

uredofos: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3033943
CHEMBL ID2105590
SCHEMBL ID1815546
MeSH IDM0059641

Synonyms (31)

Synonym
phosphoramidic acid, [[[2-[[[[(4-methylphenyl)sulfonyl]amino]carbonyl]amino]phenyl]amino]thioxomethyl]-, diethyl ester
uredofos
o,o-diethyl n-((2-(3-(4-tolylsulfonyl)ureido)phenyl)thiocarbamoyl)amidophosphat
uredofosum [inn-latin]
phosphoramidic acid, (((2-(((((4-methylphenyl)sulfonyl)amino)carbonyl)amino)phenyl)amino)thioxomethyl)-, diethyl ester
1-(3-p-tolylsulfonylureido)-2-(3-diethylphosphonothioureido)benzene
sansalid
rh 32565
phosphoroamidic acid, (((2-(((((4-methylphenyl)sulfonyl)amino)carbonyl)amino)phenyl)amino)thioxomethyl)-, diethyl ester
rh-32,565
ureidofos
diethyl (thio(o-(3-(p-tolylsulfonyl)ureido)phenyl)carbamoyl)phosphoramidate
D06267
uredofos (usan/inn)
52406-01-6
1-[2-(diethoxyphosphorylcarbamothioylamino)phenyl]-3-(4-methylphenyl)sulfonylurea
CHEMBL2105590
rh-32565
p8w25x9b3k ,
rh-565
uredofos [usan:inn:ban]
unii-p8w25x9b3k
uredofosum
uredofos [mi]
uredofos [inn]
uredofos [usan]
SCHEMBL1815546
DTXSID0073534
diethyl ((2-(3-tosylureido)phenyl)carbamothioyl)phosphoramidate
Q27286383
AKOS040747567
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
arecoline
Arecoline: An alkaloid obtained from the betel nut (Areca catechu), fruit of a palm tree. It is an agonist at both muscarinic and nicotinic acetylcholine receptors. It is used in the form of various salts as a ganglionic stimulant, a parasympathomimetic, and a vermifuge, especially in veterinary practice. It has been used as a euphoriant in the Pacific Islands.. arecoline : A tetrahydropyridine that is 1,2,5,6-tetrahydropyridine with a methyl group at position 1, and a methoxycarbonyl group at position 3. An alkaloid found in the areca nut, it acts as an agonist of muscarinic acetylcholine.		6.9510enoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine		metabolite;
muscarinic agonist
niclosamide
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48). niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.		2.3620benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide		anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
ConditionIndicatedRelationship StrengthStudiesTrials
Canine Diseases
[description not available]		03.260
Infections, Nematomorpha
[description not available]		01.9610
Intestinal Diseases, Parasitic
Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS.		01.9610
Helminthiasis, Animal
Infestation of animals with parasitic worms of the helminth class. The infestation may be experimental or veterinary.		01.9610
Helminthiasis
Infestation with parasitic worms of the helminth class.		01.9610
Bertielliasis
[description not available]		02.6430
Cystic Echinococcosis
[description not available]		01.9510
Infections, Taenia
[description not available]		02.6430
Taeniasis
Infection with tapeworms of the genus Taenia.		02.6430
Ancylostomiasis
Infection of humans or animals with hookworms of the genus ANCYLOSTOMA. Characteristics include anemia, dyspepsia, eosinophilia, and abdominal swelling.		02.3520
Trichocephaliasis
[description not available]		02.3520
Trichuriasis
Infection with nematodes of the genus TRICHURIS, formerly called Trichocephalus.		02.3520
Infections, Nematode
[description not available]		01.9510